Literature DB >> 22549089

Research priorities for global measles and rubella control and eradication.

James L Goodson1, Susan Y Chu, Paul A Rota, William J Moss, David A Featherstone, Maya Vijayaraghavan, Kimberly M Thompson, Rebecca Martin, Susan Reef, Peter M Strebel.   

Abstract

In 2010, an expert advisory panel convened by the World Health Organization to assess the feasibility of measles eradication concluded that (1) measles can and should be eradicated, (2) eradication by 2020 is feasible if measurable progress is made toward existing 2015 measles mortality reduction targets, (3) measles eradication activities should occur in the context of strengthening routine immunization services, and (4) measles eradication activities should be used to accelerate control and elimination of rubella and congenital rubella syndrome (CRS). The expert advisory panel also emphasized the critical role of research and innovation in any disease control or eradication program. In May 2011, a meeting was held to identify and prioritize research priorities to support measles and rubella/CRS control and potential eradication activities. This summary presents the questions identified by the meeting participants and their relative priority within the following categories: (1) measles epidemiology, (2) vaccine development and alternative vaccine delivery, (3) surveillance and laboratory methods, (4) immunization strategies, (5) mathematical modeling and economic analyses, and (6) rubella/CRS control and elimination.
Copyright © 2012. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22549089     DOI: 10.1016/j.vaccine.2012.04.058

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Results of the rubella elimination program in Catalonia (Spain), 2002-2011.

Authors:  Irene Barrabeig; Nuria Torner; Ana Martínez; Gloria Carmona; Pilar Ciruela; Joan Batalla; Josep Costa; Sergi Hernández; Luis Salleras; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-08       Impact factor: 3.452

2.  A microneedle patch containing measles vaccine is immunogenic in non-human primates.

Authors:  Chris Edens; Marcus L Collins; James L Goodson; Paul A Rota; Mark R Prausnitz
Journal:  Vaccine       Date:  2015-03-12       Impact factor: 3.641

3.  Thermostability of Measles and Rubella Vaccines in a Microneedle Patch.

Authors:  Jessica C Joyce; Marcus L Collins; Paul A Rota; Mark R Prausnitz
Journal:  Adv Ther (Weinh)       Date:  2021-07-28

4.  An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model.

Authors:  Stefanie A Krumm; Dan Yan; Elise S Hovingh; Taylor J Evers; Theresa Enkirch; G Prabhakar Reddy; Aiming Sun; Manohar T Saindane; Richard F Arrendale; George Painter; Dennis C Liotta; Michael G Natchus; Veronika von Messling; Richard K Plemper
Journal:  Sci Transl Med       Date:  2014-04-16       Impact factor: 17.956

Review 5.  Synergizing vaccinations with therapeutics for measles eradication.

Authors:  Richard K Plemper; Anthea L Hammond
Journal:  Expert Opin Drug Discov       Date:  2013-12-05       Impact factor: 6.098

6.  Accelerating measles and rubella elimination through research and innovation - Findings from the Measles & Rubella Initiative research prioritization process, 2016.

Authors:  Gavin B Grant; Balcha G Masresha; William J Moss; Mick N Mulders; Paul A Rota; Saad B Omer; Abigail Shefer; Jennifer L Kriss; Matt Hanson; David N Durrheim; Robert Linkins; James L Goodson
Journal:  Vaccine       Date:  2019-03-20       Impact factor: 3.641

7.  Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.

Authors:  Jennifer L Kriss; Gavin B Grant; William J Moss; David N Durrheim; Abigail Shefer; Paul A Rota; Saad B Omer; Balcha G Masresha; Mick N Mulders; Matt Hanson; Robert W Linkins; James L Goodson
Journal:  Vaccine       Date:  2019-03-18       Impact factor: 3.641

Review 8.  Vaccine chronicle in Japan.

Authors:  Tetsuo Nakayama
Journal:  J Infect Chemother       Date:  2013-07-09       Impact factor: 2.211

9.  Vaccine receipt and vaccine card availability among children of the apostolic faith: analysis from the 2010-2011 Zimbabwe demographic and health survey.

Authors:  Jennifer Lara Kriss; James Goodson; Zorodzai Machekanyanga; Messeret Eshetu Shibeshi; Fussum Daniel; Balcha Masresha; Reinhard Kaiser
Journal:  Pan Afr Med J       Date:  2016-05-11

10.  A 'post-honeymoon' measles epidemic in Burundi: mathematical model-based analysis and implications for vaccination timing.

Authors:  Katelyn C Corey; Andrew Noymer
Journal:  PeerJ       Date:  2016-09-15       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.